Roivant Sciences Ltd
ROIV
Market Cap$9.18B
Close$
$-3.56
131.3% downside
Current Fair Value
131.3% downsideOvervalued by 131.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.18 Billion |
|---|---|
| Enterprise Value | $3.01 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $5.73 |
| Beta | 1.0 |
| Outstanding Shares | 805,846,006 |
| Avg 30 Day Volume | 4,541,277 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 2.06 |
|---|---|
| PEG | -0.13 |
| Price to Sales | - |
| Price to Book Ratio | 1.63 |
| Enterprise Value to Revenue | 24.46 |
| Enterprise Value to EBIT | -2.88 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
ESG Score
No data